全文获取类型
收费全文 | 8979篇 |
免费 | 924篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 295篇 |
妇产科学 | 186篇 |
基础医学 | 1168篇 |
口腔科学 | 135篇 |
临床医学 | 994篇 |
内科学 | 1918篇 |
皮肤病学 | 64篇 |
神经病学 | 768篇 |
特种医学 | 315篇 |
外国民族医学 | 5篇 |
外科学 | 1222篇 |
综合类 | 262篇 |
现状与发展 | 1篇 |
一般理论 | 15篇 |
预防医学 | 1054篇 |
眼科学 | 223篇 |
药学 | 865篇 |
中国医学 | 2篇 |
肿瘤学 | 366篇 |
出版年
2022年 | 57篇 |
2021年 | 135篇 |
2020年 | 87篇 |
2019年 | 156篇 |
2018年 | 161篇 |
2017年 | 131篇 |
2016年 | 144篇 |
2015年 | 154篇 |
2014年 | 222篇 |
2013年 | 304篇 |
2012年 | 454篇 |
2011年 | 481篇 |
2010年 | 234篇 |
2009年 | 219篇 |
2008年 | 443篇 |
2007年 | 483篇 |
2006年 | 439篇 |
2005年 | 462篇 |
2004年 | 446篇 |
2003年 | 375篇 |
2002年 | 375篇 |
2001年 | 283篇 |
2000年 | 284篇 |
1999年 | 219篇 |
1998年 | 100篇 |
1997年 | 117篇 |
1996年 | 96篇 |
1995年 | 63篇 |
1994年 | 73篇 |
1993年 | 72篇 |
1992年 | 174篇 |
1991年 | 170篇 |
1990年 | 156篇 |
1989年 | 135篇 |
1988年 | 121篇 |
1987年 | 135篇 |
1986年 | 120篇 |
1985年 | 119篇 |
1984年 | 100篇 |
1983年 | 95篇 |
1982年 | 81篇 |
1981年 | 64篇 |
1980年 | 65篇 |
1979年 | 125篇 |
1978年 | 71篇 |
1977年 | 71篇 |
1974年 | 64篇 |
1973年 | 62篇 |
1972年 | 57篇 |
1968年 | 65篇 |
排序方式: 共有9918条查询结果,搜索用时 15 毫秒
991.
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3 下载免费PDF全文
Hookham MB Elliott J Suessmuth Y Staerk J Ward AC Vainchenker W Percy MJ McMullin MF Constantinescu SN Johnston JA 《Blood》2007,109(11):4924-4929
The somatic JAK2 valine-to-phenylalanine (V617F) mutation has been detected in up to 90% of patients with polycythemia and in a sizeable proportion of patients with other myeloproliferative disorders such as essential thrombocythemia and idiopathic myelofibrosis. Suppressor of cytokine signaling 3 (SOCS3) is known to be a strong negative regulator of erythropoietin (EPO) signaling through interaction with both the EPO receptor (EPOR) and JAK2. We report here that JAK2 V617F cannot be regulated and that its activation is actually potentiated in the presence of SOCS3. Instead of acting as a suppressor, SOCS3 enhanced the proliferation of cells expressing both JAK2 V617F and EPOR. Additionally, although SOCS1 and SOCS2 are degraded in the presence of JAK2 V617F, turnover of SOCS3 is inhibited by the JAK2 mutant kinase and this correlated with marked tyrosine phosphorylation of SOCS3 protein. We also observed constitutive tyrosine phosphorylation of SOCS3 in peripheral blood mononuclear cells (PBMCs) derived from patients homozygous for the JAK2 V617F mutant. These findings suggest that the JAK2 V617F has overcome normal SOCS regulation by hyperphosphorylating SOCS3, rendering it unable to inhibit the mutant kinase. Thus, JAK2 V617F may even exploit SOCS3 to potentiate its myeloproliferative capacity. 相似文献
992.
993.
994.
995.
996.
Dichlorvos has been in widespread use as an insecticide for over 40 years, during which time its carcinogenicity and genotoxicity have been evaluated extensively. In vitro genotoxicity assays--have shown dichlorvos to be a direct acting genotoxicant at high concentrations, consistent with its known chemical reactivity. This activity is greatly reduced in the presence of S9-mix providing auxiliary metabolic activation, again consistent with its known chemistry and metabolism. Dichlorvos has been examined in a number of in vivo genotoxicity assays using a range of cell types and endpoints, and whilst there are some reports of activity, a critical evaluation has shown that there is no convincing evidence that dichlorvos has significant genotoxic activity in vivo under exposure conditions relevant to potential human exposures. In combination with the extensive carcinogenicity database for dichlorvos, the weight of evidence indicates that dichlorvos is not genotoxic under exposure conditions relevant to those that might occur in humans. 相似文献
997.
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution 总被引:1,自引:0,他引:1
Abikoff H Arnold LE Newcorn JH Elliott GR Hechtman L Severe JB Wigal T Shapiro C Cantwell DP Conners CK Greenhill LL Hinshaw SP Hoza B Jensen PS Kraemer HC March JS Pelham WE Swanson JM Vitiello B Wells KC 《Journal of the American Academy of Child and Adolescent Psychiatry》2002,41(5):498-504
Treatment studies in child and adolescent psychiatry are increasingly characterized by long-term, multisite, randomized clinical trials (RCTs). During the course of these RCTs it is common for clinical exigencies to emerge that require rapid, direct intervention. The challenge is to provide clinically appropriate responses that do not contaminate the delivery, distinctness, and interpretation of the treatments under investigation. In multisite studies, the problem is compounded by the need to minimize cross-site differences in the delivery of adjunct treatments. Such minimization requires fully operationalized and manual-based procedures for clinically mandated intervention. The NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)--"the MTA"--is a long-term multisite collaborative study in which children with ADHD were randomly assigned to either medication management, behavioral treatment, the combination, or community-comparison assessment and referral. In designing its study, the MTA developed a manual-based set of procedures (the MTA Adjunct Services and Attrition Prevention [ASAP] Manual) for situations not covered by the protocol treatments. The majority of cases requiring adjunct services fell into two major categories: (1) crisis/emergent situations and (2) imminent risk of attrition. This report describes the ASAP guidelines for dealing with cases that required adjunct services that the MTA Steering Committee adopted before initiating the trial. Although the manual-based guidelines are especially applicable to multisite RCTs, many of the procedures in the ASAP Manual can apply to any treatment study in children. 相似文献
998.
999.
1000.
Lynch GW Slaytor EK Elliott FD Saurajen A Turville SG Sloane AJ Cameron PU Cunningham AL Halliday GM 《Experimental dermatology》2003,12(5):700-711
Langerhans' cells (LC) of skin are CD4 expressing, dendritic, antigen-presenting cells, that are essential for activation of primary immune responses and are productively infected by HIV. We have shown previously that lymphocytes and monocytes express CD4 both as monomers and covalently linked homodimers. In those cells the 55-kDa monomer structure predominates. LC in un-fractionated human epidermal cell (EC) suspension also expresses both forms of CD4, but in EC the dimer form is predominant. Because isolation of LC into single cell suspension by trypsin, as is routinely used for LC isolation, degrades CD4, a systematic study for an alternate procedure for LC isolation was performed. Thus it was found that collagenase blend F treatment can efficiently release LC into suspension, under conditions of only minimal degradation of control soluble recombinant CD4 or CEM-T4 or THP-1 cell CD4, or importantly of LC surface CD4. SDS-PAGE immunoblotting of purified LC extracted from EC by collagenase confirmed CD4 structure as predominantly 110-kDa dimers, with only minimal 55-kDa monomers. The suitability of LC prepared thus for functional studies was demonstrated with binding of functional ligand HIV gp120. It remains to be determined, however, why tissue embedded LC express mainly CD4 dimers, but single-celled blood lymphocytes and monocytes mainly monomers. 相似文献